샘플 요청 목록

 카트 문의
시장보고서
상품코드
1771536

세계의 조영제 주입기 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 종류별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Contrast Media Injectors Market Size, Share & Trends Analysis Report By Product (Injector Systems, Consumables), By Type (Single Head, Dual Head), By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2030
발행일: | 리서치사: Grand View Research | 페이지 정보: 영문 140 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

조영제 주입기 시장 성장과 동향:

Grand View Research, Inc.의 최신 보고서에 따르면, 세계 조영제 주입기 시장은 2025년부터 2030년까지 10.87%의 CAGR을 기록하며 2030년까지 37억 5,000만 달러에 달할 것으로 예상됩니다.

이 시장은 최소침습 수술에 대한 수요 증가와 일부 진단 절차에서 소모품 사용량 증가가 조영제 주입기 시장 성장을 뒷받침하고 있어 성장이 예상됩니다.

COVID-19는 2019년 조영제 주입기 시장에 큰 영향을 미쳤으며, 봉쇄 조치의 발동과 영상 진단 사례 수의 급격한 감소로 인해 매출은 약 30-40% 감소했습니다. 그러나 시장은 2022년까지 2019년의 최고치를 회복할 것으로 예상됩니다. 이는 COVID-19 백신 출시와 규제 완화, 원자재 수출입 재개로 인해 예측 기간 동안 시장이 크게 성장할 것으로 예상됩니다.

조영제 주입기의 IT화 솔루션과 같은 기술 발전은 최소침습 수술에 대한 수요 증가와 함께 향후 몇 년 동안 시장을 견인할 것으로 예상됩니다. 또한, 많은 수술 중 영상 처치가 시행되고 있는 것은 이러한 주입기에 대한 수요를 더욱 증가시켜 시장 성장을 촉진하고 있습니다.

조영제 주입기 시장 : 분석 개요

  • 제품별로는 조영제 주입기 시장의 CAGR은 10.94%로 주입기 시스템 부문이 가장 빠르게 성장하고 있습니다. 이는 혈관질환, 암 등의 진단 및 치료에 대한 적용이 확대되고 있기 때문입니다.
  • 유형별로는 단일 헤드 인젝터 부문이 2024년 조영제 인젝터 시장을 독점했습니다.
  • 용도별로는 방사선 부문이 2024년 매출 점유율의 약 45.47%를 차지했습니다.
  • 최종 용도별로는 병원 부문이 2024년 매출 점유율의 약 69.26%를 차지하며 시장을 지배했습니다. 이는 이들 시설이 조영제 주입기의 주요 사용자이며, 리듬 및 전기적 활동을 기록하고 임상 및 연구 목적으로 결과를 자세히 평가할 필요가 있기 때문입니다.
  • 아시아태평양은 예측 기간 동안 가장 빠르게 성장하는 시장 중 하나입니다. 시장 성장의 요인으로는 노인 인구의 증가와 수술 건수의 증가 등을 들 수 있습니다.

목차

제1장 분석 방법·범위

제2장 주요 요약

제3장 조영제 주입기 시장 : 변수, 동향, 범위

  • 시장 연관 전망
    • 상부 시장 전망
  • 시장 역학
    • 시장 성장 촉진요인 분석
    • 시장 성장 억제요인 분석
    • 시장 기회 분석
    • 시장 과제 분석
  • 조영제 주입기 시장 : 분석 툴
    • 업계 분석 : Porter's Five Forces 분석
    • PESTEL 분석

제4장 조영제 주입기 시장 : 제품별 추정·동향 분석

  • 부문 대시보드
  • 세계의 조영제 주입기 시장 : 변동 분석, 제품별
  • 세계의 조영제 주입기 시장 : 시장 규모와 동향 분석, 제품별(2018-2030년)
  • 인젝터 시스템
    • CT용 인젝터 시스템
    • MRI용 인젝터 시스템
    • 심혈관/혈관조영 인젝터 시스템
  • 소모품
    • 튜브
    • 주사기
    • 기타

제5장 조영제 주입기 시장 : 종류별 추정·동향 분석

  • 부문 대시보드
  • 세계의 조영제 주입기 시장 : 변동 분석, 종류별
  • 세계의 조영제 주입기 시장 : 시장 규모와 동향 분석, 종류별(2018-2030년)
  • 싱글 헤드 인젝터
  • 듀얼 헤드 인젝터
  • 시린지리스 인젝터

제6장 조영제 주입기 시장 : 용도별 추정·동향 분석

  • 부문 대시보드
  • 세계의 조영제 주입기 시장 : 변동 분석, 용도별
  • 세계의 조영제 주입기 시장 : 시장 규모와 동향 분석, 용도별(2018-2030년)
  • 방사선과
  • 인터벤션심장학
  • 인터벤션방사선학

제7장 조영제 주입기 : 최종 용도별 추정·동향 분석

  • 부문 대시보드
  • 세계의 조영제 주입기 시장 : 변동 분석, 최종 용도별
  • 세계의 조영제 주입기 시장 : 시장 규모와 동향 분석, 최종 용도별(2018-2030년)
  • 병원
    • 병원 시장 추정과 예측(2018-2030년)
  • 진단 센터
    • 진단 센터 시장 추정과 예측(2018-2030년)
  • 외래 수술 센터
    • 외래 수술 센터 시장 추정과 예측(2018-2030년)

제8장 조영제 주입기 시장 : 지역별 추정·동향 분석

  • 지역 대시보드
  • 시장 규모 예측과 동향 분석(2018-2030년)
  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 이탈리아
    • 스페인
    • 덴마크
    • 스웨덴
    • 노르웨이
  • 아시아태평양
    • 일본
    • 인도
    • 중국
    • 한국
    • 호주
    • 태국
  • 라틴아메리카
    • 브라질
    • 아르헨티나
  • 중동 및 아프리카
    • 남아프리카공화국
    • 사우디아라비아
    • 아랍에미리트
    • 쿠웨이트

제9장 경쟁 구도

  • 시장 진입 기업 분류
  • 주요 기업 개요
    • Bayer
    • Bracco Group
    • Ulrich Medical
    • Guerbet Group
    • Shenzhen Boon Medical Supply Co., Ltd
    • B.Braun SE
    • Shenzhen Antmed Co., Ltd.
    • Siemens Medical Solutions USA, Inc.(Siemens Healthineers AG)
    • Ecomed Solutions
    • Nemoto Kyorindo Co., Ltd
    • MEDTRON AG
  • 히트맵 분석/기업 시장 상황 분석
  • 기업별 시장 점유율 예측·분석(2024년)
  • 기타 주요 기업 리스트
ksm 25.07.24

Contrast Media Injectors Market Growth & Trends:

The global contrast media injectors market is expected to reach USD 3.75 billion by 2030, registering a CAGR of 10.87% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is expected to grow because of the rising demand for minimally invasive surgical procedures, along with the increasing usage of consumables for several diagnostic procedures, which are supporting the market growth of contrast media injectors.

COVID-19 had a significant impact on the contrast media injector market, in 2019, with around a 30-40% reduction in sales due to the imposed lockdown and rapid decline in imaging case volume. However, the market is expected to return to peak levels of 2019 by 2022. This is due to the launch of COVID-19 vaccines and ease in restrictions, import & export of raw materials have resumed; therefore, the market is expected to grow at a significant rate over the forecast period.

Technological advancements such as IT-enabled solutions for contrast media injectors, along with growing demand for minimally invasive surgical procedures, are expected to boost the market during the coming years. Furthermore, the large number of intraoperative imaging procedures being performed has further enhanced the demand for these injectors, propelling the market growth.

Contrast Media Injectors Market Report Highlights:

  • By product, injector systems segment is the fastest growing, with a CAGR of 10.94% in the contrast media injector market, due to its growing application in the diagnosis and treatment of vascular disease, cancer, and others
  • By type, the single-head injector segment dominated the contrast media injector market in 2024, because of their wide usage in the field of angiography, CT, and MRI as well these products are inexpensive
  • Based on the application, the radiology segment dominated the market with around 45.47% of the revenue share in 2024, because it is the primary procedure used for the diagnosis of several chronic diseases
  • Based on the end-use, the hospitals segment dominated the market with around 69.26% of the revenue share in 2024, due to the fact that these facilities are primary users of the contrast media injectors because of their need to record the rhythm & electrical activity and evaluate the results in detail for clinical & research purposes
  • Asia Pacific region is one of the fastest-growing markets during the forecast period. Factors that can be attributed to market growth include the growing geriatric population and an increasing number of surgeries

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Type
    • 1.1.3. Application
    • 1.1.4. End-use
    • 1.1.5. Regional scope
    • 1.1.6. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Contrast Media Injectors Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing burden of chronic diseases
      • 3.2.1.2. Advancements in technology
      • 3.2.1.3. Growing demand for imaging tests
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Potential complications and risks associated with contrast media injections
    • 3.2.3. Market opportunity analysis
      • 3.2.3.1. Expanding healthcare infrastructure in emerging markets
      • 3.2.3.2. Increasing research activities
      • 3.2.3.3. Growing adoption of syringeless products
    • 3.2.4. Market challenge analysis
      • 3.2.4.1. Shortage of radiologists and healthcare professionals
  • 3.3. Contrast Media Injectors Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. Contrast Media Injectors Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Contrast Media Injectors Market Product Movement Analysis
  • 4.3. Global Contrast Media Injectors Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Injector Systems
    • 4.4.1. Injector systems market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.2. CT injector systems
      • 4.4.2.1. CT injector systems market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.3. MRI injector systems
      • 4.4.3.1. MRI injector systems market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.4. Cardiovascular/angiography injector systems
      • 4.4.4.1. Cardiovascular/angiography injector systems market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5. Consumables
    • 4.5.1. Consumables market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2. Tubing
      • 4.5.2.1. Tubing market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.3. Syringe
      • 4.5.3.1. Syringe market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.4. Others
      • 4.5.4.1. Other market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Contrast Media Injectors Market: Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Contrast Media Injectors Market Type Movement Analysis
  • 5.3. Global Contrast Media Injectors Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 5.4. Single Head Injectors
    • 5.4.1. Single Head Injectors market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5. Dual-Head Injectors
    • 5.5.1. Dual-Head Injectors market estimates and forecast 2018 to 2030 (USD Million)
  • 5.6. Syringeless Injectors
    • 5.6.1. Syringeless Injectors market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Contrast Media Injectors Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Contrast Media Injectors Market Type Movement Analysis
  • 6.3. Global Contrast Media Injectors Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 6.4. Radiology
    • 6.4.1. Radiology Injectors market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5. Interventional Cardiology
    • 6.5.1. Interventional Cardiology market estimates and forecast 2018 to 2030 (USD Million)
  • 6.6. Interventional Radiology
    • 6.6.1. Interventional Radiology market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Contrast Media Injectors: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Contrast Media Injectors Market End-Use Movement Analysis
  • 7.3. Global Contrast Media Injectors Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 7.4. Hospitals
    • 7.4.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
  • 7.5. Diagnostic Centers
    • 7.5.1. Operating rooms market estimates and forecast 2018 to 2030 (USD Million)
  • 7.6. Ambulatory Surgery Centers
    • 7.6.1. Ambulatory Surgery Centers market estimates and forecast 2018 to 2030 (USD Million)

Chapter 8. Contrast Media Injectors Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Dashboard
  • 8.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 8.3. North America
    • 8.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key country dynamics
      • 8.3.2.2. Competitive scenario
      • 8.3.2.3. Regulatory framework
      • 8.3.2.4. Reimbursement scenario
      • 8.3.2.5. U.S. market estimates and forecasts, 2018 - 2030
    • 8.3.3. Canada
      • 8.3.3.1. Key country dynamics
      • 8.3.3.2. Competitive scenario
      • 8.3.3.3. Regulatory framework
      • 8.3.3.4. Reimbursement scenario
      • 8.3.3.5. Canada market estimates and forecasts, 2018 - 2030
    • 8.3.4. Mexico
      • 8.3.4.1. Key country dynamics
      • 8.3.4.2. Competitive scenario
      • 8.3.4.3. Regulatory framework
      • 8.3.4.4. Reimbursement scenario
      • 8.3.4.5. Mexico market estimates and forecasts, 2018 - 2030
  • 8.4. Europe
    • 8.4.1. UK
      • 8.4.1.1. Key country dynamics
      • 8.4.1.2. Competitive scenario
      • 8.4.1.3. Regulatory framework
      • 8.4.1.4. Reimbursement scenario
      • 8.4.1.5. UK market estimates and forecasts, 2018 - 2030
    • 8.4.2. Germany
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Competitive scenario
      • 8.4.2.3. Regulatory framework
      • 8.4.2.4. Reimbursement scenario
      • 8.4.2.5. Germany market estimates and forecasts, 2018 - 2030
    • 8.4.3. France
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Competitive scenario
      • 8.4.3.3. Regulatory framework
      • 8.4.3.4. Reimbursement scenario
      • 8.4.3.5. France market estimates and forecasts, 2018 - 2030
    • 8.4.4. Italy
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Competitive scenario
      • 8.4.4.3. Regulatory framework
      • 8.4.4.4. Reimbursement scenario
      • 8.4.4.5. Italy market estimates and forecasts, 2018 - 2030
    • 8.4.5. Spain
      • 8.4.5.1. Key country dynamics
      • 8.4.5.2. Competitive scenario
      • 8.4.5.3. Regulatory framework
      • 8.4.5.4. Reimbursement scenario
      • 8.4.5.5. Spain market estimates and forecasts, 2018 - 2030
    • 8.4.6. Denmark
      • 8.4.6.1. Key country dynamics
      • 8.4.6.2. Competitive scenario
      • 8.4.6.3. Regulatory framework
      • 8.4.6.4. Reimbursement scenario
      • 8.4.6.5. Denmark market estimates and forecasts, 2018 - 2030
    • 8.4.7. Sweden
      • 8.4.7.1. Key country dynamics
      • 8.4.7.2. Competitive scenario
      • 8.4.7.3. Regulatory framework
      • 8.4.7.4. Reimbursement scenario
      • 8.4.7.5. Sweden market estimates and forecasts, 2018 - 2030
    • 8.4.8. Norway
      • 8.4.8.1. Key country dynamics
      • 8.4.8.2. Competitive scenario
      • 8.4.8.3. Regulatory framework
      • 8.4.8.4. Reimbursement scenario
      • 8.4.8.5. Norway market estimates and forecasts, 2018 - 2030
  • 8.5. Asia Pacific
    • 8.5.1. Japan
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Competitive scenario
      • 8.5.1.3. Regulatory framework
      • 8.5.1.4. Reimbursement scenario
      • 8.5.1.5. Japan market estimates and forecasts, 2018 - 2030
    • 8.5.2. India
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Competitive scenario
      • 8.5.2.3. Regulatory framework
      • 8.5.2.4. Reimbursement scenario
      • 8.5.2.5. India market estimates and forecasts, 2018 - 2030
    • 8.5.3. China
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Competitive scenario
      • 8.5.3.3. Regulatory framework
      • 8.5.3.4. Reimbursement scenario
      • 8.5.3.5. China market estimates and forecasts, 2018 - 2030
    • 8.5.4. South Korea
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Competitive scenario
      • 8.5.4.3. Regulatory framework
      • 8.5.4.4. Reimbursement scenario
      • 8.5.4.5. South Korea market estimates and forecasts, 2018 - 2030
    • 8.5.5. Australia
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Competitive scenario
      • 8.5.5.3. Regulatory framework
      • 8.5.5.4. Reimbursement scenario
      • 8.5.5.5. Australia market estimates and forecasts, 2018 - 2030
    • 8.5.6. Thailand
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Competitive scenario
      • 8.5.6.3. Regulatory framework
      • 8.5.6.4. Reimbursement scenario
      • 8.5.6.5. Thailand market estimates and forecasts, 2018 - 2030
  • 8.6. Latin America
    • 8.6.1. Brazil
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Competitive scenario
      • 8.6.1.3. Regulatory framework
      • 8.6.1.4. Reimbursement scenario
      • 8.6.1.5. Brazil market estimates and forecasts, 2018 - 2030
    • 8.6.2. Argentina
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Competitive scenario
      • 8.6.2.3. Regulatory framework
      • 8.6.2.4. Reimbursement scenario
      • 8.6.2.5. Argentina market estimates and forecasts, 2018 - 2030
  • 8.7. MEA
    • 8.7.1. South Africa
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Competitive scenario
      • 8.7.1.3. Regulatory framework
      • 8.7.1.4. Reimbursement scenario
      • 8.7.1.5. South Africa market estimates and forecasts, 2018 - 2030
    • 8.7.2. Saudi Arabia
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Competitive scenario
      • 8.7.2.3. Regulatory framework
      • 8.7.2.4. Reimbursement scenario
      • 8.7.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
    • 8.7.3. UAE
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Competitive scenario
      • 8.7.3.3. Regulatory framework
      • 8.7.3.4. Reimbursement scenario
      • 8.7.3.5. UAE market estimates and forecasts, 2018 - 2030
    • 8.7.4. Kuwait
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Competitive scenario
      • 8.7.4.3. Regulatory framework
      • 8.7.4.4. Reimbursement scenario
      • 8.7.4.5. Kuwait market estimates and forecasts, 2018 - 2030

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Key Company Profiles
    • 9.2.1. Bayer
      • 9.2.1.1. Company overview
      • 9.2.1.2. Financial performance
      • 9.2.1.3. Product benchmarking
      • 9.2.1.4. Strategic initiatives
    • 9.2.2. Bracco Group
      • 9.2.2.1. Company overview
      • 9.2.2.2. Financial performance
      • 9.2.2.3. Product benchmarking
      • 9.2.2.4. Strategic initiatives
    • 9.2.3. Ulrich Medical
      • 9.2.3.1. Company overview
      • 9.2.3.2. Financial performance
      • 9.2.3.3. Product benchmarking
      • 9.2.3.4. Strategic initiatives
    • 9.2.4. Guerbet Group
      • 9.2.4.1. Company overview
      • 9.2.4.2. Financial performance
      • 9.2.4.3. Product benchmarking
      • 9.2.4.4. Strategic initiatives
    • 9.2.5. Shenzhen Boon Medical Supply Co., Ltd
      • 9.2.5.1. Company overview
      • 9.2.5.2. Financial performance
      • 9.2.5.3. Product benchmarking
      • 9.2.5.4. Strategic initiatives
    • 9.2.6. B.Braun SE
      • 9.2.6.1. Company overview
      • 9.2.6.2. Financial performance
      • 9.2.6.3. Product benchmarking
      • 9.2.6.4. Strategic initiatives
    • 9.2.7. Shenzhen Antmed Co., Ltd.
      • 9.2.7.1. Company overview
      • 9.2.7.2. Financial performance
      • 9.2.7.3. Product benchmarking
      • 9.2.7.4. Strategic initiatives
    • 9.2.8. Siemens Medical Solutions USA, Inc. (Siemens Healthineers AG)
      • 9.2.8.1. Company overview
      • 9.2.8.2. Financial performance
      • 9.2.8.3. Product benchmarking
      • 9.2.8.4. Strategic initiatives
    • 9.2.9. Ecomed Solutions
      • 9.2.9.1. Company overview
      • 9.2.9.2. Financial performance
      • 9.2.9.3. Product benchmarking
      • 9.2.9.4. Strategic initiatives
    • 9.2.10. Nemoto Kyorindo Co., Ltd
      • 9.2.10.1. Company overview
      • 9.2.10.2. Financial performance
      • 9.2.10.3. Product benchmarking
      • 9.2.10.4. Strategic initiatives
    • 9.2.11. MEDTRON AG
      • 9.2.11.1. Company overview
      • 9.2.11.2. Financial performance
      • 9.2.11.3. Product benchmarking
      • 9.2.11.4. Strategic initiatives
  • 9.3. Heat Map Analysis/ Company Market Position Analysis
  • 9.4. Estimated Company Market Share Analysis, 2024
  • 9.5. List of Other Key Market Players
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제